Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2023.
- Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2023.
- “In 2023, we reached many milestones in our commercial, clinical and product development programs,” said Asaf Danziger, Novocure’s Chief Executive Officer.
- Operational updates for the fourth quarter ended December 31, 2023:
1,564 prescriptions were received in the quarter, an increase of 14% year-over-year. - Novocure will host a conference call and webcast to discuss fourth quarter and full year 2023 financial results at 8:00 a.m. EST today, Thursday, February 22, 2024.